Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Lett Appl Microbiol ; 75(6): 1569-1578, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36087054

ABSTRACT

This study aimed to detect different genotypes of Candida glabrata isolates in paediatric patients with and without neutropenia utilizing microsatellite length polymorphism (MLP) and its correlation with drug resistance and enzymatic activity were assessed. Samples from neutropenic and non-neutropenic patients were collected from November 2020 to November 2021. Thirty-six C. glabrata strains were isolated and identified using classical and molecular methods. Then, C. glabrata isolates were genotyped by the MLP technique, and their antifungal susceptibility was performed based on the CLSI M27 guideline. Eighteen different multi-loci genotypes (G1-G18) were detected based on MLP analysis. Analysis of molecular variance revealed high genetic variation within populations (94%) and low genetic differentiation amongst populations (6%). Also, 40% (n = 4) of isolates from neutropenic patients were non-wild-type for posaconazole, and 30% (n = 3) were resistant to caspofungin. Very strong hemolytic and proteinase activity were seen in 97·2 and 86·1% of isolates. Candida glabrata strains from neutropenic patients were genetically divergent from other populations. The minimum spanning tree shows that observed genotypes were mainly related to previously reported genotypes from Iran, Spain, and China.


Subject(s)
Antifungal Agents , Candida glabrata , Humans , Child , Candida glabrata/genetics , Antifungal Agents/pharmacology , Drug Resistance, Fungal , Microbial Sensitivity Tests , Microsatellite Repeats , Genetic Variation
2.
J Appl Microbiol ; 131(2): 1017-1027, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33460500

ABSTRACT

AIMS: The present study aimed to determine the microsatellite length polymorphism (MLP) genotypic patterns and antifungal susceptibility profiles of Candida albicans isolated from patients with candiduria. METHODS AND RESULTS: DNA of 50 C. albicans isolates was used for molecular identification based on the ITS1 -5.8s-ITS2 region. MLP assays were performed to amplify three loci (EF3, CDC3 and HIS3), and PCR products were used for fragment analysis. Antifungal susceptibility tests were performed according to CLSI M27 4th ed guidelines. In all, 38 different genotypes were detected with the three polymorphic loci among C. albicans isolates, and only one genotype was homozygous. In comparison to other countries, our genotypes were divided into three clusters, two of which were linked to France and a third of which was linked to Austria. The genetic structures of the 50 C. albicans isolates revealed varied heterozygosity and significant Hardy-Weinberg equilibrium at the EF3 locus. Only one (2%) and four (8%) of isolates showed resistance to fluconazole and itraconazole, respectively. In C. albicans genotype G25, one (2%) of the isolates showed cross-resistance and non-wild-type resistance to posaconazole, itraconazole and fluconazole. CONCLUSION: MLP typing is a useful tool to analyse the genetic structure of C. albicans isolates. High genetic diversity (38 genotypes) was detected in the isolates tested here. Compared to isolates in other countries, the ones from our patients had a clear relationship with French and Austrian isolates. SIGNIFICANCE AND IMPACT OF THE STUDY: Iranian isolates of C. albicans have a distinct genotype and show similarities only with French and Austrian isolates.


Subject(s)
Candida albicans , Urinary Tract Infections , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Candida/drug effects , Candida albicans/drug effects , Candida albicans/genetics , Child , Drug Resistance, Fungal/drug effects , Drug Resistance, Fungal/genetics , Fluconazole , Genotype , Humans , Iran , Microbial Sensitivity Tests , Urinary Tract Infections/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...